Bryony Sheaves1, Kate Porcheret2, Athanasios Tsanas3, Colin A Espie2, Russell G Foster2, Daniel Freeman1, Paul J Harrison1, Katharina Wulff2, Guy M Goodwin1. 1. Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. 2. Nuffield Department of Clinical Neurosciences, University of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford, UK. 3. Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford; Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford, UK.
Abstract
STUDY OBJECTIVES: To group participants according to markers of risk for severe mental illness based on subsyndromal symptoms reported in early adulthood and evaluate attributes of sleep across these risk categories. METHODS: An online survey of sleep and psychiatric symptomatology (The Oxford Sleep Survey) was administered to students at one United Kingdom university. 1403 students (undergraduate and postgraduate) completed the survey. The median age was 21 (interquartile range = 20-23) and 55.60% were female. The cross-sectional data were used to cluster participants based on dimensional measures of psychiatric symptoms (hallucinations, paranoia, depression, anxiety, and (hypo)mania). High, medium, and low symptom groups were compared across sleep parameters: insomnia symptoms, nightmares, chronotype, and social jet lag. RESULTS: Insomnia symptoms, nightmares frequency, and nightmare-related distress increased in a dose-response manner with higher reported subsyndromal psychiatric symptoms (low, medium, and high). The high-risk group exhibited a later chronotype (mid sleep point for free days) than the medium- or low-risk group. The majority of participants (71.7%) in the high-risk group screened positive for insomnia and the median nightmare frequency was two per 14 days (moderately severe pathology). CONCLUSIONS: Insomnia, nightmares, and circadian phase delay are associated with increased subsyndromal psychiatric symptoms in young people. Each is a treatable sleep disorder and might be a target for early intervention to modify the subsequent progression of psychiatric disorder.
STUDY OBJECTIVES: To group participants according to markers of risk for severe mental illness based on subsyndromal symptoms reported in early adulthood and evaluate attributes of sleep across these risk categories. METHODS: An online survey of sleep and psychiatric symptomatology (The Oxford Sleep Survey) was administered to students at one United Kingdom university. 1403 students (undergraduate and postgraduate) completed the survey. The median age was 21 (interquartile range = 20-23) and 55.60% were female. The cross-sectional data were used to cluster participants based on dimensional measures of psychiatric symptoms (hallucinations, paranoia, depression, anxiety, and (hypo)mania). High, medium, and low symptom groups were compared across sleep parameters: insomnia symptoms, nightmares, chronotype, and social jet lag. RESULTS: Insomnia symptoms, nightmares frequency, and nightmare-related distress increased in a dose-response manner with higher reported subsyndromal psychiatric symptoms (low, medium, and high). The high-risk group exhibited a later chronotype (mid sleep point for free days) than the medium- or low-risk group. The majority of participants (71.7%) in the high-risk group screened positive for insomnia and the median nightmare frequency was two per 14 days (moderately severe pathology). CONCLUSIONS: Insomnia, nightmares, and circadian phase delay are associated with increased subsyndromal psychiatric symptoms in young people. Each is a treatable sleep disorder and might be a target for early intervention to modify the subsequent progression of psychiatric disorder.
Authors: Robert M A Hirschfeld; Charles Holzer; Joseph R Calabrese; Myrna Weissman; Michael Reed; Marilyn Davies; Mark A Frye; Paul Keck; Susan McElroy; Lydia Lewis; Jonathan Tierce; Karen D Wagner; Elizabeth Hazard Journal: Am J Psychiatry Date: 2003-01 Impact factor: 18.112
Authors: Till Roenneberg; Tim Kuehnle; Peter P Pramstaller; Jan Ricken; Miriam Havel; Angelika Guth; Martha Merrow Journal: Curr Biol Date: 2004-12-29 Impact factor: 10.834
Authors: Allison G Harvey; D Anne Schmidt; Antonina Scarnà; Christina Neitzert Semler; Guy M Goodwin Journal: Am J Psychiatry Date: 2005-01 Impact factor: 18.112
Authors: Bryony Sheaves; Paul E Bebbington; Guy M Goodwin; Paul J Harrison; Colin A Espie; Russell G Foster; Daniel Freeman Journal: Psychiatry Res Date: 2016-04-26 Impact factor: 3.222
Authors: Daniel Freeman; Bryony Sheaves; Guy M Goodwin; Ly-Mee Yu; Alecia Nickless; Paul J Harrison; Richard Emsley; Annemarie I Luik; Russell G Foster; Vanashree Wadekar; Christopher Hinds; Andrew Gumley; Ray Jones; Stafford Lightman; Steve Jones; Richard Bentall; Peter Kinderman; Georgina Rowse; Traolach Brugha; Mark Blagrove; Alice M Gregory; Leanne Fleming; Elaine Walklet; Cris Glazebrook; E Bethan Davies; Chris Hollis; Gillian Haddock; Bev John; Mark Coulson; David Fowler; Katherine Pugh; John Cape; Peter Moseley; Gary Brown; Claire Hughes; Marc Obonsawin; Sian Coker; Edward Watkins; Matthias Schwannauer; Kenneth MacMahon; A Niroshan Siriwardena; Colin A Espie Journal: Lancet Psychiatry Date: 2017-09-06 Impact factor: 27.083
Authors: Dan Denis; Thalia C Eley; Fruhling Rijsdijk; Helena M S Zavos; Robert Keers; Colin A Espie; Annemarie I Luik; Isabella Badini; Sarah Derveeuw; Alvin Romero; John Hodsoll; Alice M Gregory Journal: BMJ Open Date: 2017-12-01 Impact factor: 2.692